循环氨醇的晚期功能化和抗炎研究
Yong Wang1, Yingchuan Que1, Yi Gu1
1State Key Laboratory of Synergistic Chem-Bio Synthesis, Shanghai Key Laboratory for Molecular Engineering of Chiral Drugs, School of Chemistry and Chemical Engineering, Shanghai Jiao Tong University, Shanghai 200240, China.
Bioorganic & medicinal chemistry letters
|October 24, 2025
概括
环氨醇 (CAG) 具有抗炎作用,但溶解性较差. 化学修饰提高了溶解度,化衍生物 (11a) 通过减少氧化和关键细胞因子,显示出强大的抗炎活性.
科学领域:
- 自然产品化学 自然产品化学
- 药理学 药理学是指药理学的学科.
- 药用化学 医学化学
背景情况:
- 环氨基醇 (CAG) 是黄奇的关键成分,具有抗炎性质.
- 较差的水溶性限制了CAG的治疗应用.
- 开发可溶性CAG衍生物对于提高生物可用性和疗效至关重要.
研究的目的:
- 通过化学修饰来提高环氨醇 (CAG) 的水溶性.
- 为了合成和描述新的CAG衍生品.
- 为了评估改性CAG化合物的抗炎潜力.
主要方法:
- 化,硫化和糖化CAG衍生物的合成.
- 对合成化合物的水溶性进行评估.
- 使用LPS诱导的RAW264.7巨细胞对抗炎症活性进行体外评估,测量氧化 (NO) 和细胞因子水平 (IL-6,TNF-α).
主要成果:
- 在C3位置的化学修饰成功提高了CAG的水溶性.
- 化衍生物 (11a) 显示出较强的氧化物 (NO) 生产抑制.
- 无论是CAG还是衍生物11a,都显著降低了促炎性细胞因子IL-6和TNF-α.
结论:
- 化学修饰是一种有效的策略,可以克服CAG的溶解性差,同时保持生物活性.
- 化衍生物11a显示出作为一种强大的抗炎剂的显著前景.
- 为了潜在的治疗应用,需要进一步开发衍生物11a.
相关概念视频
Antiasthma Drugs: Leukotriene Modifiers
1.7K
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Leukotriene modifiers work through two distinct mechanisms:
1.7K
Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids
1.5K
Inhaled corticosteroids (ICS) are anti-inflammatory drugs used primarily in treating persistent asthma and providing long-term maintenance. They target the bronchial mucosa, the lining of the airways, to control inflammation, a critical factor in asthma progression and exacerbation.
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
1.5K
Drugs for Treatment of Ulcerative Colitis in IBD
452
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...
452


